Introduction and Commentary: Paving the Way for Biosimilars in Oncology, Part 3

Jame Abraham
2014 Seminars in Oncology  
doi:10.1053/j.seminoncol.2014.03.010 pmid:24767631 fatcat:p7mghfm4w5dlri7vdxgnt3ko3a